336 related articles for article (PubMed ID: 27114030)
1. Intention-to-treat survival analysis of hepatitis C virus/human immunodeficiency virus coinfected liver transplant: Is it the waiting list?
Araiz JJ; Serrano MT; García-Gil FA; Lacruz EM; Lorente S; Sánchez JI; Suarez MA
Liver Transpl; 2016 Sep; 22(9):1186-96. PubMed ID: 27114030
[TBL] [Abstract][Full Text] [Related]
2. Beyond the NIH Multicenter HIV Transplant Trial Experience: Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Coinfected Recipients in the United States.
Sawinski D; Goldberg DS; Blumberg E; Abt PL; Bloom RD; Forde KA
Clin Infect Dis; 2015 Oct; 61(7):1054-62. PubMed ID: 26082506
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection.
Terrault NA; Roland ME; Schiano T; Dove L; Wong MT; Poordad F; Ragni MV; Barin B; Simon D; Olthoff KM; Johnson L; Stosor V; Jayaweera D; Fung J; Sherman KE; Subramanian A; Millis JM; Slakey D; Berg CL; Carlson L; Ferrell L; Stablein DM; Odim J; Fox L; Stock PG;
Liver Transpl; 2012 Jun; 18(6):716-26. PubMed ID: 22328294
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of orthotopic liver transplantation in human immunodeficiency virus-infected patients and comparison with human immunodeficiency virus-negative cases.
Baccarani U; Adani GL; Bragantini F; Londero A; Comuzzi C; Rossetto A; Lorenzin D; Bresadola V; Risaliti A; Pea F; Toniutto P; Donini A; De Anna D; Bresadola F; Tavio M; Viale P
Transplant Proc; 2011 May; 43(4):1119-22. PubMed ID: 21620067
[TBL] [Abstract][Full Text] [Related]
5. Hemophilia Liver Transplantation Observational Study.
Ragni MV; Humar A; Stock PG; Blumberg EA; Eghtesad B; Fung JJ; Stosor V; Nissen N; Wong MT; Sherman KE; Stablein DM; Barin B
Liver Transpl; 2017 Jun; 23(6):762-768. PubMed ID: 27935212
[TBL] [Abstract][Full Text] [Related]
6. Decreasing mortality and disease severity in hepatitis C patients awaiting liver transplantation in the United States.
Kwong A; Kim WR; Mannalithara A; Heo NY; Udompap P; Kim D
Liver Transpl; 2018 Jun; 24(6):735-743. PubMed ID: 29125676
[TBL] [Abstract][Full Text] [Related]
7. Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients.
Locke JE; Durand C; Reed RD; MacLennan PA; Mehta S; Massie A; Nellore A; DuBay D; Segev DL
Transplantation; 2016 Jan; 100(1):141-6. PubMed ID: 26177090
[TBL] [Abstract][Full Text] [Related]
8. Effect of diabetes and acute rejection on liver transplant outcomes: An analysis of the organ procurement and transplantation network/united network for organ sharing database.
Kuo HT; Lum E; Martin P; Bunnapradist S
Liver Transpl; 2016 Jun; 22(6):796-804. PubMed ID: 26850091
[TBL] [Abstract][Full Text] [Related]
9. Association of serum albumin and aspartate transaminase with 5-year all-cause mortality in HIV/hepatitis C virus coinfection and HIV monoinfection.
Scherzer R; Heymsfield SB; Rimland D; Powderly WG; Tien PC; Bacchetti P; Shlipak MG; Grunfeld C;
AIDS; 2017 Jan; 31(1):71-79. PubMed ID: 27677166
[TBL] [Abstract][Full Text] [Related]
10. Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis.
Merchante N; Rivero-Juárez A; Téllez F; Merino D; José Ríos-Villegas M; Márquez-Solero M; Omar M; Macías J; Camacho A; Pérez-Pérez M; Gómez-Mateos J; Rivero A; Antonio Pineda J;
Hepatology; 2012 Jul; 56(1):228-38. PubMed ID: 22278746
[TBL] [Abstract][Full Text] [Related]
11. Management of liver transplantation waiting list for decompensated cirrhosis in a Spanish tertiary hospital: differences between hepatitis C virus recipients and other etiologies.
Ibáñez Samaniego L; Pérez Valderas M; Fernández Yunquera A; Rincón Rodríguez D; López Baena JA; Matilla Peña A; Catalina Rodríguez MV; Clemente Ricote G; Bañares Cañizares R; Salcedo Plaza M
Transplant Proc; 2014 Nov; 46(9):3084-6. PubMed ID: 25420829
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection.
Price JC; Ma Y; Scherzer R; Korn N; Tillinghast K; Peters MG; Noworolski SM; Tien PC
Hepatology; 2017 Mar; 65(3):853-863. PubMed ID: 27981599
[TBL] [Abstract][Full Text] [Related]
13. Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the National Institutes of Health multi-site study.
Bahirwani R; Barin B; Olthoff K; Stock P; Murphy B; Rajender Reddy K;
Liver Transpl; 2013 Jun; 19(6):619-26. PubMed ID: 23512786
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in waiting list composition.
Crespo G; Trota N; Londoño MC; Mauro E; Baliellas C; Castells L; Castellote J; Tort J; Forns X; Navasa M
J Hepatol; 2018 Jul; 69(1):11-17. PubMed ID: 29481821
[TBL] [Abstract][Full Text] [Related]
15. Risk of echocardiographic pulmonary hypertension in individuals with human immunodeficiency virus-hepatitis C virus coinfection.
Sangal RB; Taylor LE; Gillani F; Poppas A; Klinger JR; Ventetuolo CE
Ann Am Thorac Soc; 2014 Dec; 11(10):1553-9. PubMed ID: 25375659
[TBL] [Abstract][Full Text] [Related]
16. Improved Survival After Liver Transplantation for Patients With Human Immunodeficiency Virus (HIV) and HIV/Hepatitis C Virus Coinfection in the Integrase Strand Transfer Inhibitor and Direct-Acting Antiviral Eras.
Jacob JS; Shaikh A; Goli K; Rich NE; Benhammou JN; Ahmed A; Kim D; Rana A; Goss JA; Naggie S; Lee TH; Kanwal F; Cholankeril G
Clin Infect Dis; 2023 Feb; 76(4):592-599. PubMed ID: 36221143
[TBL] [Abstract][Full Text] [Related]
17. Recipient female gender is a risk factor for graft loss after liver transplantation for chronic hepatitis C: Evidence from the prospective Liver Match cohort.
Belli LS; Romagnoli R; Nardi A; Marianelli T; Donato F; Corradini SG; Iemmolo RM; Morelli C; Pasulo L; Rendina M; De Martin E; Ponziani FR; Volpes R; Strazzabosco M; Angelico M;
Dig Liver Dis; 2015 Aug; 47(8):689-94. PubMed ID: 26055490
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C Virus Positive Patients on the Waiting List for Liver Transplantation: Turnover and Characteristics of the Population on the Eve of the Therapeutic Revolution With Direct-Acting Antivirals.
Trapani S; Rizzato L; Masiero L; Ricci A; Morabito V; Peritore D; Fiaschetti P; Del Sordo E; Cacciotti AR; Montemurro A; Nanni Costa A
Transplant Proc; 2017 May; 49(4):658-666. PubMed ID: 28457366
[TBL] [Abstract][Full Text] [Related]
19. Retrospective-prospective study of safety and efficacy of sofosbuvir-based direct-acting antivirals in HIV/HCV-coinfected participants with decompensated liver disease pre- or post-liver transplant.
Peters MG; Kottilil S; Terrault N; Amara D; Husson J; Huprikar S; Florman S; Sulkowski MS; Durand CM; Luetkemeyer AF; Rogers R; Grab J; Haydel B; Blumberg E; Dove L; Emond J; Olthoff K; Smith C; Fishbein T; Masur H; Stock PG
Am J Transplant; 2021 May; 21(5):1780-1788. PubMed ID: 33277801
[TBL] [Abstract][Full Text] [Related]
20. Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?
Rockstroh JK; Peters L; Grint D; Soriano V; Reiss P; Monforte Ad; Beniowski M; Losso MH; Kirk O; Kupfer B; Mocroft A;
J Hepatol; 2013 Aug; 59(2):213-20. PubMed ID: 23583272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]